China on Thursday announced that as of March 1, carfentanil and three other similar substances would be effectively banned. The U.S. Drug Enforcement Agency says the news could be a “game-changer” for the opioid epidemic in the U.S., which has been hit hard by the use of synthetics like carfentanil.
Here & Now‘s Jeremy Hobson talks with Wall Street Journal China correspondent Brian Spegele (@bspegele) about China’s decision and what it could mean for Americans.
Copyright 2021 NPR. To see more, visit https://www.npr.org.